Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Clinical Study to Evaluate the Novel Netrod™ Renal Denervation System and the Impact of Sham vs Open-Label Control in European Patients With Uncontrolled Primary Hypertension in the Absence of Hypertensive Medication

NCT06722651 is registered in ClinicalTrials.gov with Shanghai Golden Leaf MedTec Co. Ltd as lead sponsor.

NCT NCT06722651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Clinical Study to Evaluate the Novel Netrod™ Renal Denervation System and the Impact of Sham vs Open-Label Control in European Patients With Uncontrolled Primary Hypertension in the Absence of Hypertensive Medication
Lead sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Phase
Not applicable
Overall status
Withdrawn
Start date
August 30, 2025
Completion date
August 31, 2031
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled hypertension